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ABSTRACT: Administration of flumequine and oxolinic acid to halibut Hippoglossus hippoglossus by 
bath resulted in significant tissue levels of both the antibactenals. Bath treatment using 150 mg 1-' of 
flumequine and 200 mg 1-' of oxolinic acid for 72 h resulted in flunlequine concentrations of 14.2 pg g-' 
in muscle and 85.4 pg g-' in abdominal organ homogenate and oxolinic acid concentrations of 9.4 pg 
g-' in muscle and 72.6 pg g-' in abdominal organ homogenate. Excretion of both antibacterials was 
rapid and characterised by elunination half-lives (t1,2) of 10 and 15.6 h respectively for flumequine and 
oxolinic acid In muscle and 9.8 and 15.0 h respectively in the abdominal organ homogenate. The cor- 
responding elimination times (E,) were 6.5 and 8 d respectively for flumequine and oxolinic acid in 
muscle and 7.5 and 9 d respectively in abdominal organ homogenate when a maximum residue con- 
centration of 0.05 pg g-' was applied for both drugs. The minimum inhibitory concentration (MIC) 
against strains of Vibrio sp. ranged from 0.015 to 1.0 pg m]-' for flurnequine and 0.015 to 0.5 pg ml-' for 
oxolinic acid. Following bath treatment, tissue levels of flumequine and oxolinic acid greater than MIC 
for susceptible strains (<0.0625 pg rnl-') were maintained for up to 6.5 and 8 d respectively for flume- 
quine and oxolinic acid in muscle and 7.5 and 9 d respectively in abdominal organ homogenate. 
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INTRODUCTION 
Flumequine (FLU) and oxolinic acid (OXA) are 
broad-spectrum synthetic antibacterial agents and 
members of the 4-quinolone series of antibacterials. 
Quinolones are especially active against Gram- 
negative bacteria and have been recommended for 
the treatment of urinary tract and enteric infections 
in humans (Wolfson & Hooper 1989). The antibacter- 
ial activity of quinolones is based on the inhibition of 
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DNA-gyrase resulting in an unstable condensation of 
the DNA configuration of the bacterial DNA mole- 
cule during cell division (Wolfson & Hooper 1989). 
Flumequine and OXA have been used intensively to 
treat systemic bacterial infections such as furunculo- 
sis caused by Aeromonas salmonicjda, vibriosis 
caused b y  Vibrio anguillarum and enteric redmouth 
disease caused by Yersinia rucken in fish (Michel et 
al. 1980, Austin et al. 1983, Rodgers & Austin 1983, 
Scallan & Smith 1985, O'Grady et al. 1988). The 
widespread use of FLU and OXA for the treatment of 
bacterial infections in fish is mainly due to their rela- 
tively low minimum inhibitory concentrations (MIC) 
for most susceptible fish pathogens (Martinsen 1993) 
and effective systemic distribution when adrninis- 
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tered orally via medicated feed (Chevalier et al. 
1981). 
Injection into the peritonea1 cavity or muscle repre- 
sents the most effective and accurate means of admin- 
istering a therapeutic dose of an antibacterial agent to 
an  individual fish. However, since individual injection 
is costly in time and labour and causes stress to the fish 
it is inappropriate as a routine method of chemother- 
apy. At present, injection is only used in the treatment 
of valuable broodstock fish. Oral administration of 
drugs using food pellets containing the desired anti- 
bacterial substance permits treatment of large quanti- 
ties of fish relatively easily at a moderate cost in labour 
and has become the prime route of medication. How- 
ever, diseased fish often show reduced appetite, which 
together with hierarchical behaviour will result in 
uneven distribution of the antibacterial in the stock. 
This gives rise to a situation where only healthy indi- 
viduals that are still feeding are protected by the 
antibacterial. Bath treatment offers an equal dose to 
both healthy and diseased fish and is easy to carry out 
with agents of sufficient water-solubility. Being re- 
stricted to tanks of limited size, bath treatment may be 
an alternative in treating small fish where the feed 
uptake is minimal due to infection, low temperature or 
early stages of development. It has previously been 
demonstrated that bath administration of erythromycin 
with surfactant could eliminate Aeromonas salmoni- 
cida from the intestine of fish (Roberts 1980). Bath 
treatment with FLU was shown to successfully elimi- 
nate stress inducible furunculosis in Atlantic salmon 
Salmo salar smolts (O'Grady & Smith 1992). Bath 
administration of sulphon.amides and trimethoprim has 
shown the drugs to be well absorbed in both rainbow 
trout Oncorhynchus mykiss and cod Gadus morhua 
(Bergsjs 1974, Bergsjs & Bergsjs 1978, Bergsj0 & Ssg- 
nen 1980, Borgan et al. 1981). 
Several studies have addressed the pharmacokinet- 
ics of OXA and FLU in fish held in seawater (Hustvedt 
& Salte 1991, Hustvedt et al. 1991, Ishida 1992, Rogstad 
et al. 1993, Elema et al. 1994, Martinsen & Horsberg 
1995). However, information on the pharmacokinetic 
properties of quinolones admin~stered by bath to hal- 
ibut is not presently available in the literature. 
The aim of this study was to determine the absorp- 
tion, tissue distribution and elimination of FLU and 
OXA in halibut following bath treatment, and also the 
in vitro MIC values for the drugs against some strains 
of Vibrio sp. 
MATERIALS AND METHODS 
Chemicals. Flu.mequine (FLU) and oxolinic acid 
(OXA) were obtained from Norsk Medisinaldepot 
(Rergen, Norway). Methanol, acetonitrile, tetrahydro- 
furan (HPLC-grade), sodium hydroxide (NaOH) and 
oxalic acid dihydrate were all from Vercks (Darm- 
stadt, Germany). 
Chromatography. The HPLC system used consisted 
of a Spectra-Physics SP 8800 ternary HPLC-pump 
(Spectra-Physics, San Jose, Cl\, USA) connected to a 
Spectra-Physics SP 8780 X R Autosampler and a Shi- 
madzu RF-535 fluorescence detector (Shimadzu, 
Kyoto, Japan) operating at an excitation wavelength of 
325 nm and an emission wavelength of 360 nm. The 
integrator was the model SP-4270 from Spectra- 
Physics. The HPLC system was programmed to inject 
20 p1 samples into the 150 X 4.6 mm analytical column 
packed with 3 pm particles of MOS-Hypersil (C-8), 
(Shandon Southern Products, Astmoor, UK) in our lab- 
oratory using a Shandon column packing machine. 
The column was operated at room temperature. The 
mobile phase used contained A: 0.025 M oxalic acid 
pH 3.2 - acetonitrile - methanol - tetrahydrofuran (80 - 
2.5 - 15 - 2.5 v/v) and. B: oxalic acid pH 3.2 - acetonitrile 
- methanol - tetrahydrofuran (50 - 20 - 25 - 5 v/v). The 
solutions were filtered through a 0.2 pm Millipore fil- 
ter. The elusion profile was as follows: 0 to 4 min., 50 to 
100% B linear gradient; 4 to 10 min. isocratic 100')L B; 
10.1 to 15 min. isocratic 50% A and 50% B. The flow 
rate was 1 m1 min.-' 
Stock solutions of FLU and OXA were prepared at a 
concentration of 0.1 mg m l '  in 0.1 M NaOH and stored 
at -20°C. Working standards were prepared by dilu- 
tion from the stock solutions with 0.1 M NaOH. 
Experimental fish. Approximately 250 halibut ob- 
tained from Tinfos Aqua (Kvinesdal, Norway), ranging 
in we~ght  from 3 to 5 g ,  were maintained in a circular 
(1 m X 2.5 m i.d.) flow-through seawater tank at the 
laboratory of the Institute of Marine Research, Bergen, 
Norway. The seawater had a salinity of 3 3 %  and a 
temperature of 12.0 * 0.5"C. Ten fish were taken prior 
to initiation of the study and analysed by HPLC to 
confirm th.e absence of FLU and OXA from the tissues. 
Tissues from these fish also served as samples for the 
calibration curves. 
Bath administrations. The bath administrations were 
carried out in 40 1 glass aquaria contaiming 20 1 of the 
drug solution. The drugs were dissolved in 50 m1 of a 
0.025 M solution of NaOH and added to the seawater 
to a final concentration of 250 rng 1-' of FLU or 200 mg 
1.' of OXA. It was decided to use a FLU concentration 
of 150 mg 1-' in the bath due to lethality on 1 of 5 fish in 
a preliminary experiment using a bath concentration of 
200 mg 1-l. Extremely h ~ g h  concentrations of FLU in 
both muscle (136.4 pg g-') and abdominal organ 
homogenate (580.8 1-19 g-l) was found in the dead fish. 
Administration of FLU by bath or by injection has 
shown to be capable of causing lethal concentrations of 
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the drug in Atlantic salmon smolts (Scallan 1983, 
O'Grady & Smith 1992). A possible link between oral 
administration of FLU to Atlantic salmon pre-smolts 
and lethality has been described by Hiney et al. (1994). 
The bath solutions were aerated and the aquaria 
equipped with a filter-pump to remove fecal particles. 
Twenty-four hours prior to initiating bath treatment the 
test fish were transferred to the aquaria for acclimati- 
sation. The fish were kept in the drug solution for 72 h 
followed by transfer of the remaining fish to flow- 
through seawater tanks containing unmedicated sea- 
water. Six fish were removed at 24, 48 and 72 h during 
treatment and at the following times post treatment: 1, 
3, 5, 7, 10 and 14 d. The sampled fish were rinsed in 
clean seawater in order to avoid contamination of the 
samples by drug-containing water. The fish were 
killed by a blow to the head and kept at -20°C until 
analysed. 
Sample preparation. Samples of muscle and abdom- 
inal organ homogenate (0.1 g) were homogenised in 
1.0 m1 of 0.1 M NaOH solution containing the internal 
standard. Following homogenisation, 0.5 m1 of the 
homogenate was transferred to a polypropylene tube. 
After centrifugation at 12 900 X g i n  a Biofuge 13 table- 
centrifuge (Heraeus Sepatech, Osterode am Harz, 
Germany) for 5 min. and filtration of the supernatant 
through an Acrodisc LC PVDF 0.45 pm syringe filter 
(Gelman Sciences, Ann Arbor, MI, USA) a clear super- 
natant was obtained, ready for analysis. The method 
had a detection limit of 0.05 pg g-' Flumequine was 
used as internal standard for the determination of OXA 
and vice versa. Due to the small size of the fish it was 
difficult to obtain individual samples of the organs. It 
was therefore decided to use a homogenate of the 
abdominal organs as one sample. The abdominal 
organ homogenate consisted mainly of liver, stomach 
and intestine. 
Data handling. In the depletion phase, linear regres- 
sion analysis were performed on logarithn~ically (In) 
transformed tissue concentrations versus time. Elimi- 
nation half lives ( t I l 2 )  were calculated from the mono- 
exponential slope for the drug elimination. Values 
below the limit of detection were assumed to be zero 
and eliminated from the calculations. The correspond- 
ing elimination times (E,) were calculated as the time 
were the regression line intercepts with a residue con- 
centration of 0.05 1-19 g-' for the respective drugs. At 
present no official maximum residue limit (MRL) has 
been decided by the European Union for OXA or FLU 
in food products. 
Minimum inhibitory concentration (MIC) determi- 
nations. Determination of MIC values was performed 
using the agar dilution method (Washington 1985). 
Strains were maintained on Mueller Hinton Agar 
(Difco) supplemented with 2 %  NaCl. Material from 
strains to be examined was transferred to 10 m1 Difco 
Mueller Hinton Broth (Difco) supplemented with 2 % 
NaCl and incubated for 48 h at  20 "C giving a final cell 
density of approximately 5 X 10' cells ml-l. Using a 
10 p1 inoculation loop, bacteria from this broth were 
distributed on the surface of Mueller Hinton Agar sup- 
plemented with 2 % NaCl and containing FLU or OXA. 
The antibacterial agents were added to the agar in 
2-fold dilutions from newly prepared stock solutions. 
The temperature of the agar on addition of the agents 
were 50°C. Following incubation at 20°C for 72 h the 
plates were examined for bacterial growth. The lowest 
concentration of FLU and OXA at which complete inhi- 
bition occurred was recorded as the MIC. 
Bacterial strains. In the determination of MIC values 
the following bacterial strains were examined: Vibrio 
anguillarum serotype 0 1  (HI 11341), V anguillarum 
serotype 0 2  a (HI 11347), V salmonicida (HI 10448) 
and V splendidus (1576/92). The first 2 strains are 
pathogenic to halibut whereas the strains of V 
salmonicida and V splendidus are non-pathogenic but 
were originally isolated from halibut (0. Bergh, Insti- 
tute of Marine Research, Bergen, pers. comm.). 
RESULTS 
No lethality was observed during or after treatment. 
The mean concentration versus time profiles for FLU 
and OXA in muscle and abdominal organ homogenate 
are given in Figs. 1 & 2. Fish-to-fish variation ex- 
pressed as standard deviation are given as error bars. 
The % standard deviation ranged from 4 to 24 % and 
10 to 21 % respectively for FLU and OXA in muscle 
and from 14 to 26% and 10 to 46% respectively for 
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Fig. 1. Hippoglossus hippoglossus. Concentration versus time 
curves for flumequine In muscle and abdominal organ 
homogenate of halibut during and following bath treatment 
In 150 mg I- '  of the drug for 72 h 
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Fig. 2.  Hippoglossus hippoglossus. Concentration versus time 
curves for oxolinic acic in muscle and abdominal organ 
homogenate of halibut during and following bath treatment 
in 150 mg 1-' of the drug for 72 h 
abdominal organ homogenate. Peak concentrations for 
FLU and OXA following a 72 h bath treatment were 
14.2 and 9.4 pg g-' respectively in muscle and 85.4 and 
72.6 1-19 g-' respectively in abdominal organ homo- 
genate. At Day 7 post treatment, the drug concentra- 
tions in all samples were below the detection limit of 
the analytical method used. The elimination half lives 
(tl12) were calculated to be 10 and 15.6 h respectively 
for FLU and OXA in muscle and 9.8 and 15.0 h respec- 
tively in abdominal organ homogenate. The corre- 
sponding elimination times (E,) were determined to be 
6.5 and 8 d respectively in muscle and 7.5 and 9 d 
respectively in abdominal organ homogenate using a 
maximum residue concentration of 0.05 1-19 g-l. The 
correlation value (r2) for the slops from which tl12 and 
E, were calculated were 0.99, 0.99 and 0.98 respec- 
tively for muscle and abdominal organ homogenate 
(FLU) and muscle (OXA). The correlation value for 
OXA in abdominal organ homogenate was 0.944. No 
indications of 2-phase elimination for either of the 
drugs was found. The MICs against the bacterial 
strains tested in this investigation ranged from 0.015 to 
1.0 pg ml-' for FLU and from 0.015 to 0.5 pg ml-' for 
OXA (Table 1). 
DISCUSSION 
The analysis showed high concentrations of both 
FLU and OXA in muscle and abdominal organ 
homogenate of halibut. Following a 72 h bath treat- 
ment with 150 mg 1-' FLU and 200 mg 1-' OXA, peak 
concentrations of 14.2 pg g-' (FLU) and 9.4 pg g-' 
(OXA) in muscle and 85.4 pg g-' (FLU) and 72.6 pg g-' 
(OXA) in abdominal organ homogenate were ob- 
tained. These concentrations are similar or consider- 
Table 1. In vitro activity of flumequine and oxolinic acid 
against Vibrio sp. 
MIC (pg rnl- ' )  
Flumequine Oxolinic 
acid 
Vibrio anguillarum 0 1 HI 11341 0.06 0.03 
Vibrio anguillarum 0 2 a  HI 11347 0.015 0.015 
Vibrio salmonicida HI 10448 0.03 0.03 
Vibno splendidus 1576/92 1.00 0.5 
ably higher than the concentrations achieved follow- 
ing oral administration of these drugs to fish held in 
seawater. Peak concentrations following oral adminis- 
tration of FLU to Atlantic salmon (25 mg kg-' d-l for 
6 d) were 9 and 14 pg g-' respectively in muscle and 
liver (Elema et al. 1994). In a study by Rogstad et al. 
(1993) peak concentrations were 6.58 and 19.5 pg g-' 
respectively for FLU in muscle and liver of Atlantic 
salmon treated with a single oral dose of 25 mg kg-' 
fish-'.. The corresponding values for OXA were 5.72 
and 6.83 pg g-l. Ishida (1992) found peak tissue con- 
centrations of 1.2 pg g-' in muscle and 1.8 pg g-' in 
liver following a single oral administration of 40 mg 
kg-' of OXA to rainbow trout. 
Figs. 1 & 2 show that both FLU and OXA were 
rapidly eliminated from muscle and abdominal organ 
homogenate of halibut. The tIl2 of OXA in halibut 
were calculated to 15.0 and 15.6 h respectively in 
muscle and abdominal organ homogenate. This is 
shorter than the 17.6 h in muscle and 21.2 h in liver of 
Atlantic salmon found by Elema et al. (1994) but 
longer than the 10 h in plasma, muscle and liver of 
Atlantic salmon reported by Rogstad et al. (1993). The 
t l I2  of FLU in halibut were estimated to 10.0 h in 
muscle and 9.8 h in abdominal organ homogenate, 
which is shorter than any previous reported values. In 
earlier studies, t,,2 of FLU was found to be 23 and 
17.6 h in muscle and 23 and 21.2 h in liver of Atlantic 
salmon (Rogstad et al. 1993, Elema et al. 1994). Calcu- 
lated plasma t l I2  for FLU and OXA in Atlantic salmon 
and rainbow trout held in seawater varies from 11.3 to 
22.8 h for FLU (Martinsen 1993, Rogstad et al. 1993, 
Elema et al. 1994, Martinsen & Horsberg 1995) and 10 
to 60.3 h for OXA (Hustvedt & Salte 1991, Hustvedt et 
al. 1991, Rogstad et al. 1993, Martinsen & Horsberg 
1995). The times for FLU and OXA to reach a tissue 
concentration of 0.05 pg g-' were 6.5 and 8 d respec- 
tively for muscle and 7.5 and 9 d respectively for 
abdominal organ homogenate. Although these calcu- 
lations are derived from data obtained from small fish 
and cannot be direct extrapolated to larger fish, they 
indicate short withdrawal times for both quinolones in 
tissues of halibut. 
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The in vitro MIC-values for FLU and OXA against 
the bacterial strains tested ranged from 0.015 to 1.0 pg 
inl-' for FLU and from 0.015 to 0.5 1-19 ml-' for OXA 
(Table 1). Previous studies report MIC's of FLU and 
OXA against strains of Aeronlonas saln~onicida, Vibrio 
salrnonicida, V anguillarurn and Yersinia ruckeri to 
range from 0.005 to 0.5 pg ml-I, and most of the strains 
had MICs of <0.1 pg ml-' (Barnes et  al. 1990, Martin- 
sen et  al. 1992, Martinsen 1993). According to the 
guidelines proposed by Tsoumas et  al. (1989), a bac- 
terium is susceptible to FLU and OXA if the in vitro 
MIC is ~ 0 . 0 6 2 5  pg ml-' and moderately susceptible 
when the MIC is within the range of 0.125 to 0.5 pg 
ml-'. With a MIC of 21.0 pg ml-' a strain is classified as 
resistant. Using this guideline, 3 of 4 strains examined 
were susceptible to OXA and one was moderately sus- 
ceptible whereas 2 strains were susceptible to FLU, 
one was moderately susceptible and one was resistant. 
Standard oral therapy with FLU to fish in Norway is 
25 mg  kg-' d-' for 5 to 8 d and 40 mg kg-' d-' for 5 to 
8 d for OXA. The results from this investigation show 
that bath treatment using FLU and OXA at concentra- 
tions of 150 and 200 mg  1-' respectively for 72 h main- 
tained muscle levels in excess of an  MIC-value of 
0.0625 p g  ml-' for at least 6.5 d for FLU and 8 d for 
OXA. The corresponding values were 7.5 and 9 d 
respectively for FLU and OXA in abdominal organ 
homogenate. 
When a drug is added to water, there are  several 
possible absorption routes. Absorption of drugs 
through the gills is assumed to be  of major importance 
whereas absorption through the skin is of relatively lit- 
tle significance (Parry 1966). In seawater drugs can be 
absorbed via the intestine as a result of the fish drink- 
ing the surrounding medium (Motais & Garcia-Romeu 
1972). Bergsjo & B e r g s j ~  (1978) showed that the 
uptake of sulphadimidine and sulphanilamide in rain- 
bow trout was higher from salt water at pH 8.0 than 
from fresh water at pH 8.0. This indicates a supple- 
mentary absorption from the gut. However, the 
absorption rate of FLU and OXA measured in this 
investigation is very slow compared to the absorption 
rate of FLU in fish held in freshwater (O'Grady e t  al. 
1988, Hiney et  al. 1995). This indicate the presence of 
factors inhibiting absorption in seawater. An 18 min 
treatment in a freshwater bath with a FLU concentra- 
tion of 25 mg 1-' and a pH of 6.5 gave peak muscle con- 
centrations of 14 and 18.5 pg g-' in 2 groups of Atlantic 
salmon smolt (Hiney et  al. 1995). O'Grady e t  al. (1988) 
obtained serum levels of approximately 5 p g  ml-' of 
FLU in Atlantic salmon smolts following bath treat- 
ment in a 100 mg 1-' freshwater solution of pH 8.0 for 
30 min. In the same investigation it was shown that the 
absorption rate of FLU in brown trout Salmo trutta and 
Atlantic salmon smolts was highly dependent on pH 
and the presence of calcium ions (Ca2+) in the solution. 
A progressive decline in uptake occurred when pH 
was increased from 6.5 to 8 and the Ca2+ level in the 
solution was raised from 0 to 75 mg. 1-' At higher Ca2+ 
levels the decrease in FLU absorption was less pro- 
nounced. Recent research has also shown that the con- 
centration of magnesium (Mg2+) ions found in seawater 
have marked effect on both the antibacterial activity 
and  uptake of various antibacterials by fish (Lunestad 
& Gokseryr 1990, Barnes e t  al. 1995, Purse11 e t  al. 1995). 
Seawater contains approximately 10 and  54 m M  
respectively of Ca2+ and Mg2' ions and has a pH of 
approximately 8.0. The unfavourable conditions for 
FLU and OXA absorption in seawater compared to 
freshwater may explain the large differences in the 
absorption rates obtained in this study and the studies 
by O'Grady et al. (1988) and Hiney et al. (1995). 
Excluding the measurements of OXA in abdominal 
organ homogenate after 72 h ,  Figs. 1 & 2 show that the 
fish to fish variation in drug concentration is small. 
From plasma data obtained in a multiple dose study 
with oral administration of FLU to healthy Atlantic 
salmon much higher 'X standard deviations of 25 to 
65% could be calculated (Elema et al. 1994). These 
results indicate that the fish to fish variation is smaller 
using bath treatment compared to oral administration. 
In commercial conditions the feeding response will be  
via a n  infected population where it is reasonable to 
predict that the extent of fish-to-fish variation will be 
even greater than that calculated from data obtained 
by Elema et  al. (1994). In addition to the low fish-to-fish 
variation in tissue concentrations a second advantage 
of bath treatment is that fish do not need to be  actively 
feeding in order to receive therapeutic tissue levels. 
CONCLUSION 
In summary this study shows that bath treatment 
using FLU and OXA is an  alternative to oral adminis- 
tration as a chemotherapeutic method in the control of 
bacterial infections in small halibut. Both FLU and 
OXA were absorbed in sufficient amounts to achieve 
and maintain tissue levels greater than the in vitro MIC 
values for susceptible pathogens for at least 6.5 d. Pro- 
vided that oxygenation is adequate,  it is possible to 
treat a large number of fish in a comparatively small 
volume of water. The procedure is simple and  allows 
the user to dispose of and  destroy the remains of the 
drugs in a controlled manner. Due to environmental 
aspects and  the large amount of drug needed for the 
treatment, this technique is however not suitable for 
sea cage application. Further research is needed to 
evaluate the maximim size of halibut suitable for bath 
treatment. 
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